Keros Therapeutics (KROS) Capital Expenditures (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Capital Expenditures (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 220.78% |
| Sep 30, 2025 | -277.78% |
| Jun 30, 2025 | 27.43% |
| Mar 31, 2025 | 95.50% |
| Dec 31, 2024 | -25.13% |
| Sep 30, 2024 | -62.38% |
| Jun 30, 2024 | 346.09% |
| Mar 31, 2024 | -57.49% |
| Dec 31, 2023 | -1.64% |
| Sep 30, 2023 | -59.32% |
| Jun 30, 2023 | 6,338.10% |
| Mar 31, 2023 | -66.13% |
| Dec 31, 2022 | 108.84% |
| Sep 30, 2022 | -211.80% |
| Jun 30, 2022 | 620.69% |
| Mar 31, 2022 | -45.28% |
| Dec 31, 2021 | -81.62% |
| Sep 30, 2021 | 511.90% |
| Jun 30, 2021 | -200.00% |
| Sep 30, 2020 | -828.57% |